Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron May 18, 2021 6:53pm

102 Views

Post# 33227326

todays trades

House Positions for C:VXL from 20210518 to 20210518

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
1 Anonymous	34,000	3,065	0.09	6,500	615	0.095	27,500	-2,450
7 TD Sec	26,063	2,409	0.092	14,762	1,334	0.09	11,301	-1,075
79 CIBC	7,112	640	0.09	0			7,112	-640
85 Scotia	2,206	209	0.095	2,650	238	0.09	-444	29
124 Questrade	1,000	95	0.095	3,000	270	0.09	-2,000	175
9 BMO Nesbitt	0			5,000	450	0.09	-5,000	450
80 National Bank	17,267	1,606	0.093	22,883	2,131	0.093	-5,616	525
68 Leede	1,470	132	0.09	8,054	765	0.095	-6,584	633
2 RBC	27,731	2,506	0.09	54,000	4,860	0.09	-26,269	2,354
TOTAL	116,849	10,662	0.091	116,849	10,663	0.091	0	1